top
Search terms
Results 41 - 50 of 119 - ordered by :
Pages: 1 ... 2 3 4 5 6 7 8 ... 12
Ehjcvp

In this issue of European Heart Journal: Cardiovascular Pharmacology, Johnson et al. report an observational study on the relationship between conventional risk factors and the incidence of AF in ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Farhan Shahid, Eduard Shantsila, Gregory Y. H. Lip

Date : 01/04/2016 Item size : 149125 bytes
Ehjcvp

Abstract Aims An important decision in the management of patients with atrial fibrillation is whether to adopt a rate or rhythm control strategy. Methods and results We conducted a retrospective ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Carl Hayward, Hitesh C. Patel, Ketna Patel, Carlo Di Mario, Alexander R. Lyon, Syed Y. Ahsan, Edward Rowland

Date : 01/04/2016 Item size : 222623 bytes
Ehjcvp

Introduction Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) have been used in clinical practice for more than a century and are among the most widely used drugs worldwide for the ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Morten Schmidt, Morten Lamberts, Anne-Marie Schjerning Olsen, Emil Fosbøll, Alexander Niessner, Juan Tamargo, Giuseppe Rosano, ...

Date : 01/04/2016 Item size : 461588 bytes
Ehjcvp

Furthermore, it is noteworthy that the lack of a carboxyl terminus renders CNP highly susceptible to cleavage by neprilysin (NEP).6 Physiologically CNP via activation of pGC-B exhibits antifibrotic ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Johann Wojta

Date : 01/04/2016 Item size : 144952 bytes
Ehjcvp

In this issue of the journal, Sverre E. Kjeldsen and Giuseppe Mancia comment on the measurement technique for blood pressure (BP) that was used in the important SPRINT study, and they discuss whether ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Stefan Agewall

Date : 01/04/2016 Item size : 103672 bytes
Ehjcvp

SerelaxinAcute heart failureCongestion reliefOrgan protectionLong-term outcomesIntroduction Heart failure (HF) is a chronic condition, punctuated by acute episodes, which affects as many as one in ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Javier Díez, Luis M. Ruilope

Date : 01/04/2016 Item size : 577165 bytes
Ehjcvp

Abstract Aims To determine whether risk factor changes over 6 years were associated with the incidence of atrial fibrillation (AF) among middle-aged men in the Malmö Preventive Project (MPP) ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Linda S.B. Johnson, Tord Juhlin, Gunnar Engström, Peter M. Nilsson

Date : 01/04/2016
Ehjcvp

Due to the introduction of foreign materials to the circulation (either temporarily or permanently) and due to a certain damage to the endothelium or endocardium, the risk of thrombotic complications ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, P. Widimský, V. Kočka, F. Roháč, P. Osmančík

Date : 01/04/2016
Ehjcvp

While rhythm control is recommended in patients with AF-related symptoms despite rate control, this therapeutic concept has been less often applied since the publication of AFFIRM.1,2 If physicians ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Bernhard M. Kaess, Joachim R. Ehrlich

Date : 01/04/2016
Ehjcvp

Introduction Cenderitide (CD-NP) is a novel chimeric natriuretic peptide (NP) currently in clinical trials for heart failure (HF).13 As a chimeric peptide, cenderitide is a single-chemical entity ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Candace Y.W. Lee, Brenda K. Huntley, Daniel J. McCormick, Tomoko Ichiki, S. Jeson Sangaralingham, Ondrej Lisy, John C. ...

Date : 01/04/2016